ANTI-CD38-ANTIKÖRPER

Patent europeic · EP3284754 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3284754
Numer da la dumonda
EP17189925
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
30-12-2011
Publitgà
21-02-2018
Concedì
04-11-2020
La protecziun finescha il pli tard
29-12-2031
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C07K 16/28 (2006.01)
A61P 35/02 (2006.01)
Prioritad
US 201061428699 P 30.12.2010
US 201161470406 P 31.03.2011
US 201161470382 P 31.03.2011
US 201161485104 P 11.05.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 01-01-2023

    Midada

    Published in Swissreg on 01.01.2023

  5. 04-11-2020

    Concedì

    Published in Swissreg on 04.11.2020

Partidas

Possessur

Takeda Pharmaceutical Company Limited

1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP

Inventur

HAAK-FRENDSCHO, Mary

San Diego, CA 92121, US

BHASKAR, Vinay

San Diego, CA 92121, US

DRAKE, Andrew Walling

San Diego, CA 92121, US

KORVER, Wouter

San Diego, CA 92121, US

ELIAS, Kathleen Ann

San Diego, CA 92121, US

SNELL, Gyorgy Pal

San Diego, CA 92121, US

SINGH, Shweta

San Diego, CA 92121, US

LANDES, Gregory

San Diego, CA 92121, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.